RENEW OR SUBSCRIBE TO PPM
Subscription is FREE for qualified healthcare professionals in the US.
13 Articles in Volume 11, Issue #4
Diagnosing and Managing Hand Osteoarthritis
Difficult Migraine Patient
Electromagnetic Applications In Biology and Medicine
Excerpt from the Book Avoiding Opioid Abuse While Managing Pain
Hormone Therapies: Newest Advance in Pain Care
Make the Family Your Best Friend
Medications for Chronic Pain—Opioid Analgesics
Nonpharmacologic Remedies for Back Pain During Pregnancy
Reconsidering and Revising Evidence-Based Practice in Pain Medicine: Steps Toward Sustaining the Profession?
The Value of Blood Analysis for Compliance Monitoring
Treatment of Neuropathic Pain: The Role of Unique Opioid Agents
Understanding Potential Complications Of Epidural Steroid Injections
Unmasking Post-traumatic Headache

Hormone Therapies: Newest Advance in Pain Care

Severe, uncontrolled pain may exhaust the adrenal gland, resulting in low levels of pregnenolone and cortisol. While adequate pain control will usually normalize serum hormone levels, opioid-induced suppression of the system may require additional treatment.
Page 4 of 4

A profound result of recurrent, episodic pain flares is that excess cortisol enters the blood to give a “pseudo” Cushing’s syndrome. Serious side effects may result, including hypertension, hyperlipidemia, diabetes, osteoporosis, and brain tissue atrophy with loss of mental and intellectual powers. Patients with severe, chronic pain should therefore be periodically screened for cortisol excess and deficiencies. HCG is an intriguing compound that contains FSH, LH, and TSH. It also has an anabolic, tissue-building component. HCG’s labeled indication is hypogonadism, and its early clinical use indicates that it may have considerable merit as an adjunct to pain treatment. It may neutralize opioid suppression of testosterone as well as produce its own anabolic growth effects on nerve tissue.

Last updated on: September 6, 2011
SHOW MAIN MENU
SHOW SUB MENU